Accendra Health, Inc.
ACH Healthcare Medical Distribution
In the quarter to June 2026, revenue fell 10.1%, EPS grew 89.7%, free cash flow fell 1,624.8% and total debt fell 13.1%, each against the same quarter a year earlier.
Follow ACH
Accendra Health, Inc. (ACH) EV/Sales
As of 16 October 2026, Accendra Health, Inc. (ACH) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from −2.6× (September 2024) to 4.2× (July 2024); the current reading is higher than 83% of that period. That is above the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | (31.68%) |
| FY2024 | 1.1× | (19.03%) |
| FY2023 | 1.3× | 232.05% |
| FY2022 | 0.4× | (6.71%) |
| FY2021 | 0.4× | 34.04% |
| FY2020 | 0.3× | 61.05% |
| FY2019 | 0.2× | (15.54%) |
| FY2018 | 0.2× | (0.91%) |
| FY2017 | 0.2× | (19.45%) |
| FY2016 | 0.3× | (1.10%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 35.03% |
| Mar 2026 | 0.7× | (0.49%) |
| Dec 2025 | 0.7× | (77.37%) |
| Sep 2025 | 3.2× | (8.31%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| HKPD Cellyan Biotechnology Co., Ltd compare | n/m |
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| CAH Cardinal Health, Inc. compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.4× |
| ACH Accendra Health, Inc. | 0.9× |
| HSIC Henry Schein, Inc. compare | 0.9× |
| SNYRQ Synergy CHC Corp. compare | 0.9× |
| AHG Akso Health Group Sponsored ADR compare | 1.8× |
| FOCL FocalTherics compare | 2.1× |
| Medical Distribution industry median | 0.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)